A key consideration in understanding SD within neurovascular disorders is the role of vasoactive mediators such as CGRP, prostanoids, and substance P. Our findings demonstrate significant upregulation of CGRP following SD [24, 26, 30, 33], highlighting its central role in the vasodilatory component of neurogenic inflammation. This evidence concerns the gene TAC1 and neurovascular disorder.